Cigarette smoking, alcohol intake, and thyroid cancer risk: a pooled analysis of five prospective studies in the United States.
Cigarette smoking, alcohol intake, and thyroid cancer risk: a pooled analysis of five prospective studies in the United States.
复制标题
DOI:
10.1007/s10552-012-0039-2
复制
发表时间:
2012-10
影响因子:
2.3
通讯作者:
de Gonzalez, Amy Berrington
中科院分区:
文献类型:
--
作者:
Kitahara, Cari M.;Linet, Martha S.;Freeman, Laura E. Beane;Check, David P.;Church, Timothy R.;Park, Yikyung;Purdue, Mark P.;Schairer, Catherine;de Gonzalez, Amy Berrington
We examined the associations between cigarette smoking, alcohol intake, and thyroid cancer risk in a pooled analysis of five prospective studies. Data from five prospective U.S. studies were standardized and then combined into one aggregate dataset (384,433 men and 361,664 women). Pooled hazard ratios (HR) and 95% confidence intervals (CI) for thyroid cancer were estimated from mutually-adjusted models of cigarette smoking and alcohol intake, which were additionally adjusted for age, sex, education, race, marital status, body mass index, and cohort. Over follow-up, 1,003 incident thyroid cancer cases (335 men and 668 women) were identified. Compared to never smokers, current smoking was associated with reduced risk of thyroid cancer (HR=0.68, 95% CI:0.55-0.85); this association was slightly stronger among non-drinkers (HR=0.46, 95% CI:0.29-0.74). No reduction in risk was observed for former, compared to never, smokers. Greater smoking intensity, duration, and pack-years were associated with further reductions in risk among former and current smokers. Alcohol intake was also inversely associated with thyroid cancer risk (≥7 drinks/week versus 0, HR=0.72, 95% CI:0.58-0.90, P-trend=0.002). Inverse associations with smoking and alcohol were more pronounced for papillary versus follicular tumors. The results of this pooled analysis suggest that both cigarette smoking and alcohol consumption are associated with reduced risks of papillary thyroid cancer and, possibly, follicular thyroid cancer.
登录
查看更多内容
影响因子:
7
作者:
Huedo-Medina, Tania B.;Sanchez-Meca, Julio;Botella, Juan
通讯作者:
Botella, Juan
影响因子:
4.7
作者:
Nagano J;Mabuchi K;Yoshimoto Y;Hayashi Y;Tsuda N;Land C;Kodama K
通讯作者:
Kodama K
DOI:
10.1158/1055-9965.epi-08-0960
发表时间:
2009-03
期刊:
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
影响因子:
--
作者:
Enewold L;Zhu K;Ron E;Marrogi AJ;Stojadinovic A;Peoples GE;Devesa SS
通讯作者:
Devesa SS
DOI:
10.1016/0197-2456(86)90046-2
发表时间:
1986-09-01
期刊:
CONTROLLED CLINICAL TRIALS
影响因子:
--
作者:
DERSIMONIAN, R;LAIRD, N
通讯作者:
LAIRD, N
DOI:
10.1158/1055-9965.epi-10-1220
发表时间:
2011-03
期刊:
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
影响因子:
--
作者:
Kitahara CM;Platz EA;Freeman LE;Hsing AW;Linet MS;Park Y;Schairer C;Schatzkin A;Shikany JM;Berrington de González A
通讯作者:
Berrington de González A